Selected article for: "hand foot and mouth hand foot"

Author: Hsia, Shao-Hsuan; Lin, Jainn-Jim; Chan, Oi-Wa; Lin, Tzou-Yien
Title: Cardiopulmonary failure in children infected with Enterovirus A71
  • Cord-id: zwffw6ur
  • Document date: 2020_4_16
  • ID: zwffw6ur
    Snippet: Enterovirus A71 (EV-A71) is one of the causative pathogens of hand, foot, and mouth disease (HFMD), which may cause severe neurological and cardiopulmonary complications in children. In this review, we discuss the pathogenesis, clinical manifestations, management strategy, and clinical outcomes of cardiopulmonary failure (CPF) in patients with EV-A71 infection. The pathogenesis of CPF involves both catecholamine-related cardiotoxicity following brainstem encephalitis and vasodilatory shock due t
    Document: Enterovirus A71 (EV-A71) is one of the causative pathogens of hand, foot, and mouth disease (HFMD), which may cause severe neurological and cardiopulmonary complications in children. In this review, we discuss the pathogenesis, clinical manifestations, management strategy, and clinical outcomes of cardiopulmonary failure (CPF) in patients with EV-A71 infection. The pathogenesis of CPF involves both catecholamine-related cardiotoxicity following brainstem encephalitis and vasodilatory shock due to cytokine storm. Sympathetic hyperactivity, including tachycardia and hypertension, are the early clinical manifestations of cardiopulmonary involvement, which may progress to pulmonary edema/hemorrhage and/or CPF. The management strategy comprises multidisciplinary supportive treatment, including fluid management, positive pressure ventilation support, and use of milrinone, vasopressors, and inotropes. Some patients may require extracorporeal membrane oxygenation. Major neurological sequelae are almost inevitable once a child develops life-threatening illness. Long-term care of these children is an important medico-social issue.

    Search related documents:
    Co phrase search for related documents
    • long term follow study and low mortality: 1
    • long term follow study and lung heart: 1
    • low intermediate and lung heart: 1
    • low mortality and lung heart: 1, 2, 3, 4
    • low mortality and lung involvement: 1, 2, 3, 4
    • lung involvement and lymphocyte production: 1